Dovato 49702-0246
Generic: Dolutegravir Sodium And Lamivudine
Product NDC
49702-0246- Manufacturer
- Viiv Healthcare Company
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 8, 2019
- Listing Expires
- December 31, 2027
- Application
- NDA211994
Need to source Dovato? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dolutegravir Sodium | 50 mg/1 |
| Lamivudine | 300 mg/1 |
Drug Class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]HIV Integrase Inhibitors [MoA]
Packaging Options(3)
30 TABLET, FILM COATED in 1 BOTTLE (49702-246-13)
1 BLISTER PACK in 1 CARTON (49702-246-33) / 30 TABLET, FILM COATED in 1 BLISTER PACK
1 BLISTER PACK in 1 CARTON (49702-246-62) / 14 TABLET, FILM COATED in 1 BLISTER PACK